At SomnoMed patients suffering from Obstructive Sleep Apnea are at the center of our attention. We are aware that the majority of patients diagnosed with this chronic disease cannot tolerate the treatment offered with CPAP masks, are remaining untreated and are suffering severe impacts on their daily lives.
SomnoMed offers COAT (Continuous Open Airway Therapy) – a clinically proven alternative therapy - which improves the condition in over 90% of all cases and delivers medical success in over two thirds of diagnosed patients.
As global leaders in this therapy we constantly aim to deliver to patients, insurers and medical specialists treatment with a device which is very comfortable to use, durable and precision custom made to ensure an easy process of fitting the device by our global network of trained dentists.
All our products are clinically proven, have received regulatory approvals, and are produced under strict ISO 13485 manufacturing standards. SomnoMed has exceeded 200,000 patients (2014) fitted with its devices and achieved an immaculate clinical track record with a complete absence of cases showing severe side effects, malpractice or any other legal action taken against our company.
We believe that the future will continue to show an accelerating shift from CPAP to COAT based on the facts that patient compliance is significantly higher, treatment outcome is better and treatment costs are lower with SomnoMed COAT than those offered by CPAP. Our future growth will be generated through the constantly growing acceptance of COAT by medical specialists and insurers and through the continuous growth of diagnosed patients.
Latest Media Releases
29/04/2019 09:46:00
29th April 2019, SomnoMed Limited (ASX:SOM) announced that its core revenues grew by 9% in the third quarter compared to the prior year, reaching $14.3 million for the three month period. APAC deliver…
29/01/2019 14:51:00
29th January 2019, SomnoMed Limited (ASX:SOM) announced that its core revenues grew by 13% in the second quarter compared to the prior year, reaching $15.675 million for the three months period. All r…
Latest News
Stock Watch /
by Michael Gable -
4 years ago
14 Sep 2020 - Fund Manager Michael Gable discusses the Nasdaq's recent performance levels, SOM, NWH and KGN.
Market Reports /
by Ortenzia Borre -
5 years ago
30 Oct 2019 - The Australian share market opened lower in early trade tracking 0.6 per cent down at noon. Shares in Costa Group plunged 26.3 per cent when trading commenced.
Company News /
by Anna Napoli -
6 years ago
25 Jul 2018 - Diagnostic treatments company, SomnoMed (ASX:SOM) has announced its revenues for Qtr4 2018 were $17.4 million, representing growth of 22 per cent on the same period l…
Company News /
by Anna Napoli -
6 years ago
19 Mar 2018 - Dental sleep product company, SomnoMed (ASX:SOM) has announced the successful completion of its retail entitlement offer.
Company News /
by Kathy Skantzos -
7 years ago
24 Jan 2018 - Medical therapy producer SomnoMed (ASX:SOM) announces a 45 per cent growth in revenue for the second quarter of the financial year, reaching $18.5 million for the qua…
Company News /
by Kathy Skantzos -
7 years ago
26 Oct 2017 - SomnoMed (ASX:SOM) announces total revenue growth of 18.8 per cent for the September quarter to $13 million compared to the prior corresponding period.
Market Reports /
by Carolyn Herbert -
8 years ago
18 Oct 2016 - Bouncing back: Aus shares close 0.41% higher. Kidman Resources Limited (ASX:KDR) has responded to a price query from the ASX after its shares fell from 65.5 cents on …
Company News /
by David Chau -
8 years ago
18 Oct 2016 - SomnoMed Ltd (ASX:SOM) achieved record September 2016 sales, which were 23.8% higher compared to the same period last year.
Market Reports /
by -
8 years ago
20 Apr 2016 - Aus shares continue advance. Decmil Group Limited (ASX:DCG) says that it has won $24 million worth of new business.
Company News /
by -
8 years ago
20 Apr 2016 - SomnoMed Limited (ASX:SOM) says strong growth in the sales of its sleep apnea devices has lifted third quarter revenue.
Company News /
by -
9 years ago
20 Jan 2016 - SomnoMed Limited (ASX:SOM) SomnoDent devices see 30 percent increase in total sales revenue for 1H 2015/15.
Market Reports /
by -
9 years ago
10 Dec 2015 - Following weak offshore leads, the Australian share market opened lower. Mobile Embrace (ASX:MBE) has inked a deal with Asian telecommunications group Axiata.
Company News /
by -
9 years ago
03 Nov 2015 - SomnoMed Limited (ASX:SOM) has announced that its subsidiary SomnoMed Canada acquired the business of Strong Dental in Ontario for C$700,000.
Market Reports /
by -
9 years ago
13 Oct 2015 - Aus shares 0.24% lower at noon. Telstra Corporation (ASX:TLS) warns shareholders that ACCC rulings could cost the company up to $430 million in revenue and EBITDA.
Company News /
by -
9 years ago
10 Apr 2015 - SomnoMed Limited (ASX:SOM) grows revenues a further 17.3 per cent during the third quarter.
Interviews /
by -
10 years ago
17 Nov 2014 - SomnoMed Limited (ASX:SOM) Executive Chairman and CEO Dr Peter Neustadt outlines why the sleep treatment business is confident of its growth prospects.
Market Reports /
by -
10 years ago
10 Nov 2014 - Aus shares open weaker. Somnomed Limited (ASX:SOM) reaches milestone of having fitted 200,000 patients with its medical devices since its start of operations in 2004.
Market Reports /
by -
10 years ago
16 Oct 2014 - The Australian share market belted up for a wild roller coaster ride today. Iluka Resources Limited (ASX:ILU) posts flat revenue of $147.7 million in the September qu…
Company News /
by -
10 years ago
16 Oct 2014 - Sleep device maker SomnoMed Limited (ASX:SOM) grows September sales by 25 per cent year-on-year with record results across the globe.
Company News /
by -
10 years ago
03 Jun 2014 - Medical manufacturer SomnoMed Limited (ASX:SOM) launches two new products in the US.
Company News /
by -
10 years ago
10 Apr 2014 - Somnomed Limited (ASX:SOM) improves third quarter sales by 28 per cent to $6.5 million.
Market Reports /
by -
11 years ago
21 Nov 2013 - ASX sinks for fourth session. BHP Billiton Limited (ASX:BHP) predicts China’s economic growth will remain above 7 per cent in 2014.
Company News /
by -
12 years ago
09 Oct 2012 - Somnomed Limited (ASX:SOM) expands into France with the purchase of the country’s second largest oral appliance company, Orthosom.